Mass General Brigham Incorporated
Location
Massachusetts
Founded
1994-02-13
Risk Signals
1495 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., General Medical and Surgical Hospitals), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Mass General Brigham Incorporated
Live alerts from global media, monitored by Business Radar
2025-04-27 (scitechdaily.com)
AI Predicts Pediatric Brain Tumor Relapse With Surprising Accuracy
Researchers have developed an AI system that predicts brain tumor recurrence in children using sequential MRI scans. By applying a novel "temporal learning" method that processes multiple post-treatment images, the AI significantly outperforms traditional single-scan models. The approach promises
Read more
2025-04-24 (synbiobeta.com)
Bespoke CRISPR Enzymes Generated By AI for a Safer Genetic Future -
A new algorithm can predict the properties of 64 million CRISPR enzymes—making gene editing safer and more precise
Read more
2025-04-20 (lifeboat.com)
Scientists Develop New Gene Editing Tool that Replaces Entire Genes – News: The Blog
Scientists from Mass General Brigham and Beth Israel Deaconess Medical Center have developed a novel gene editing tool called STITCHR. Unlike traditional CRISPR, STITCHR inserts entire genes at precise locations, minimizing unintended mutations. This gene editing tool simplifies use and offers potential as a one-time treatment for genetic disorders. The technology uses retrotransposons, naturally occurring "jumping genes" found in all eukaryotic organisms, which can move and integrate into genomes. Using computational screening, the researchers identified and reprogrammed a specific retrotransposon to work with the nickase enzyme from CRISPR, forming the complete STITCHR system that allows a precise, seamless gene insertion into the genome. STITCHR offers the potential to replace or supplement entire genes, creating a more universal treatment option for various genetic diseases. The research team is now working to improve its efficiency and move it toward clinical use.
Read more
2025-04-16 (isaaa.org)
Scientists Develop New Gene Editing Tool that Replaces Entire Genes- (April 16, 2025) | - ISAAA.org
Scientists from Mass General Brigham and Beth Israel Deaconess Medical Center have developed a novel gene editing tool called STITCHR. Unlike traditional CRISPR, STITCHR inserts entire genes at precise locations, minimizing unintended mutations. This gene editing tool simplifies use and offers potential as a one-time treatment for genetic disorders.
Read more
2025-03-06 (beckershospitalreview.com)
Health systems building Epic tools
"Discover how two leading health systems are optimizing their EHR with Epic-integrated tools, including an AI-powered dictation feature and a frailty index for
Read more
2024-12-30 (automatyka.pl)
Draganfly on the road to success – .pl
Draganfly announced that it has completed its first flights as part of an R&D project to deliver drones to Mass General Brigham (MGB) Home...
Read more
2024-09-25 (beckershospitalreview.com)
Mass General Brigham's innovation conference: 7 highlights
Discover the top digital innovation themes from the World Medical Innovation Forum, as reported by Becker's, from generative AI to ambient documentation.
Read more
2024-09-21 (cancerletter.com)
Tampa General, Mass General Brigham strengthen relationship through BMT, CAR T collaboration
Tampa General Hospital and Mass General Brigham announced a strengthening of their affiliation with the development of new programs and services, including a bone marrow transplant program and CAR T therapy program, at TGH.
Read more
2024-09-20 (hcinnovationgroup.com)
Tampa General, Mass General Brigham Expand Affiliation
Mass General will help with development of a bone marrow transplant program and CAR-T therapy program at Tampa General
Read more
2024-09-16 (globalhealthnewswire.com)
Generative AI Model Study Shows No Racial or Sex Differences in Opioid Recommendations for Treating Pain
A new study from Mass General Brigham researchers provides evidence that large language models (LLMs), used for generative artificial intelligence (AI), ChatGPT-4 and Google’s Gemini, demonstrated no differences in suggested opioid treatment regimens for different races or sexes.
Read more
2024-09-12 (lowellsun.com)
Workforce company Bioversity 'LINCs' up with UML
LOWELL — More companies are joining the LINC project that launched in April. Bioversity, a leading Massachusetts nonprofit provider of biotech workforce training, announced that it was opening a dedicated training lab and classroom facility in Lowell.
Read more
2024-09-12 (newsbeast.gr)
Warning on ADHD drug Adderall – 'Linked to increased mental health risks'
The drug Adderall, which is commonly prescribed in the US to people with Attention Deficit Hyperactivity Disorder (ADHD), has caused concern among researchers due to its side effects, which although rare are serious, while in the last two decades it has
Read more